Therapeutic efficacy of Dahuang Zhechong pills combined with entecavir in treatment of hepatic fibrosis due to chronic hepatitis B:a report of 20 cases
Chao Chen
Abstract
Chao Chen
Abstract
Objective:To observe the therapeutic efficacy of Dahuang Zhechong pills combined with entecavir in the treatment of hepatic fibrosis due to chronic hepatitis B.Methods:Forty patients with hepatic fibrosis due to chronic hepatitis B were randomly divided into treatment group and control group.The treatment group received Dahuang Zhechong pills combined with entecavir,while the control group received entecavir combined with kushenin.The two groups were compared in terms of hepatic fibrosis indices,HBV-DNA,and B-mode ultrasound of the liver after 6 months of treatment.Results:The treatment group had a significantly better treatment outcome than the control group according to total effective rate,four hepatic fibrosis indices,HBV-DNA,and B-mode ultrasound of the liver(P 0.05).Conclusion:Dahuang Zhechong pills combined with entecavir have good therapeutic efficacy in the treatment of hepatic fibrosis due to chronic hepatitis B and show promise for clinical application.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the therapeutic efficacy of Dahuang Zhechong pills combined with entecavir in the treatment of hepatic fibrosis due to chronic hepatitis B.Methods:Forty patients with hepatic fibrosis due to chronic hepatitis B were randomly divided into treatment group and control group.The treatment group received Dahuang Zhechong pills combined with entecavir,while the control group received entecavir combined with kushenin.The two groups were compared in terms of hepatic fibrosis indices,HBV-DNA,and B-mode ultrasound of the liver after 6 months of treatment.Results:The treatment group had a significantly better treatment outcome than the control group according to total effective rate,four hepatic fibrosis indices,HBV-DNA,and B-mode ultrasound of the liver(P 0.05).Conclusion:Dahuang Zhechong pills combined with entecavir have good therapeutic efficacy in the treatment of hepatic fibrosis due to chronic hepatitis B and show promise for clinical application.
Key concepts: Entecavir, Medicine, Gastroenterology, Chronic hepatitis, Internal medicine, Pill, Hepatic fibrosis, Fibrosis